Menopause International > Volume 14, Number 3 > Pp. 105-110

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Légaré, F. Articles by Tapp, S. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original articles

Patient decision aid on natural health products for menopausal symptoms: randomized controlled trial

France Légaré ^* , Sylvie Dodin , Dawn Stacey , Annie LeBlanc ^* and Sylvie Tapp ^*

^* Research Center, Centre Hospitalier Universitaire de Québec, Québec
André et Lucie Chagnon Chair for an Integrated Approach to Health Promotion, Université Laval, Québec
Ottawa Health Research Institute, Ottawa, Canada

Correspondence: France Légaré, MD PhD, Canada Research Chair in Implementation of Shared Decision Making in Primary Care, Research Center, Centre Hospitalier Universitaire de Québec, 10 Espinay, Québec, Québec G1L 3L5, Canada. Email: France.Legare{at}mfa.ulaval.ca
Objective. To evaluate the impact of a patient decision aid (PDA) regarding the use of natural health products (NHPs) at menopause on decisional conflict, knowledge of NHPs, congruence between values and choice, persistence with an option, intention to disclose the use of NHPs to a physician or a pharmacist and intention to use decision support interventions in the future.

Study design. A randomized controlled trial in which 90 women, aged 45–64 years, facing a decision about using NHPs for menopausal symptoms, received a PDA (experimental group) or a general information brochure about menopause (control group).

Main outcome. Decisional conflict.

Measures. Women were evaluated at baseline and after a two-week period using the decisional conflict scale (DCS). Analysis of covariance was used to determine the differences between both groups on the DCS.

Results. Both groups experienced a statistically significant reduction on the DCS (–0.55 ± 0.59, P < 0.0001 versus –0.52 ± 0.73, P < 0.0001). However, there was no statistically significant difference between the groups (P = 0.32). Both groups experienced a statistically significant improvement in knowledge of NHPs (0.86 ± 1.77, P = 0.002 versus 0.51 ± 1.47, P = 0.031). However, there was no statistically significant difference between the groups (P = 0.162).

Conclusion. A PDA regarding the use of NHPs for menopausal symptoms impacted favourably on women's decisional conflict, but was not superior to a general information brochure on menopause.

Key Words: Menopause • natural health products • patient decision aids • randomized controlled trial • women's health

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?